PubMed

Managing type 2 diabetes: going beyond glycemic control.

Stolar MW, Hoogwerf BJ, Gorshow SM, Boyle PJ, Wales DO.

J Manag Care Pharm. 2008 Jun;14(5 Suppl B):s2-19.PMID: 18597582 [PubMed - indexed for MEDLINE]Related articlesFree article

Type 2 diabetes, cardiovascular risk, and the link to insulin resistance.

Stolar MW, Chilton RJ.

Clin Ther. 2003;25 Suppl B:B4-31. Review.PMID: 14553864 [PubMed - indexed for MEDLINE]Related articles

Insulin resistance, diabetes, and the adipocyte.

Stolar MW.

Am J Health Syst Pharm. 2002 Dec 1;59 Suppl 9:S3-8. Review.PMID: 12489380 [PubMed - indexed for MEDLINE]Related articles

Clinical management of the NIDDM patient. Impact of the American Diabetes Association practice guidelines, 1985-1993. Endocrine Fellows Foundation Study Group.

Stolar MW.

Diabetes Care. 1995 May;18(5):701-7.PMID: 8586012 [PubMed - indexed for MEDLINE]Related articles

Atherosclerosis in diabetes: the role of hyperinsulinemia.

Stolar MW.

Metabolism. 1988 Feb;37(2 Suppl 1):1-9. Review.PMID: 3277013 [PubMed - indexed for MEDLINE]Related articles

The metabolic clearance, distribution, and degradation of dimeric and monomeric growth hormone (GH): implications for the pattern of circulating GH forms.

Baumann G, Stolar MW, Buchanan TA.

Endocrinology. 1986 Oct;119(4):1497-501.PMID: 3530720 [PubMed - indexed for MEDLINE]Related articles

Secretory patterns of growth hormone during basal periods in man.

Stolar MW, Baumann G.

Metabolism. 1986 Sep;35(9):883-8.PMID: 3747844 [PubMed - indexed for MEDLINE]Related articles

Molecular forms of human growth hormone secreted in vivo: nonspecificity of secretory stimuli.

Baumann G, Stolar MW.

J Clin Endocrinol Metab. 1986 Apr;62(4):789-90.PMID: 3081572 [PubMed - indexed for MEDLINE]Related articles

Big growth hormone forms in human plasma: immunochemical evidence for their pituitary origin.

Stolar MW, Baumann G.

Metabolism. 1986 Jan;35(1):75-7.PMID: 3941610 [PubMed - indexed for MEDLINE]Related articles

A specific growth hormone-binding protein in human plasma: initial characterization.

Baumann G, Stolar MW, Amburn K, Barsano CP, DeVries BC.

J Clin Endocrinol Metab. 1986 Jan;62(1):134-41.PMID: 3940261 [PubMed - indexed for MEDLINE]Related articles

Slow metabolic clearance rate of the 20,000-dalton variant of human growth hormone: implications for biological activity.

Baumann G, Stolar MW, Buchanan TA.

Endocrinology. 1985 Oct;117(4):1309-13.PMID: 4029078 [PubMed - indexed for MEDLINE]Related articles

Molecular forms of circulating growth hormone during spontaneous secretory episodes and in the basal state.

Baumann G, Stolar MW, Amburn K.

J Clin Endocrinol Metab. 1985 Jun;60(6):1216-20.PMID: 3889030 [PubMed - indexed for MEDLINE]Related articles

Circulating growth hormone forms after stimulation of pituitary secretion with growth hormone-releasing factor in man.

Stolar MW, Baumann G, Vance ML, Thorner MO.

J Clin Endocrinol Metab. 1984 Aug;59(2):235-9.PMID: 6429181 [PubMed - indexed for MEDLINE]Related articles

Plasma "big" and "big-big" growth hormone (GH) in man: an oligomeric series composed of structurally diverse GH monomers.

Stolar MW, Amburn K, Baumann G.

J Clin Endocrinol Metab. 1984 Aug;59(2):212-8.PMID: 6376529 [PubMed - indexed for MEDLINE]Related articles